Cargando…

Enhancing glioblastoma treatment through the integration of tumor-treating fields

Glioblastoma (GBM) represents a significant therapeutic challenge due to its aggressive nature. Tumor Treating Fields (TTFields) present a promising approach to GBM therapy. The primary mechanism of TTFields, an antimitotic effect, alongside numerous indirect effects including increased cell membran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szklener, Katarzyna, Bilski, Mateusz, Nieoczym, Karolina, Mańdziuk, Dominika, Mańdziuk, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616854/ https://www.ncbi.nlm.nih.gov/pubmed/37916157 http://dx.doi.org/10.3389/fonc.2023.1274587

Ejemplares similares

New Directions in the Therapy of Glioblastoma
por: Szklener, Katarzyna, et al.
Publicado: (2022)

Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions
por: Szklener, Katarzyna, et al.
Publicado: (2022)

New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors
por: Szklener, Katarzyna, et al.
Publicado: (2022)

Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
por: Szklener, Katarzyna, et al.
Publicado: (2023)

Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
por: Szklener, Katarzyna, et al.
Publicado: (2022)

Phytochemicals in Cancer Treatment and Cancer Prevention—Review on Epidemiological Data and Clinical Trials
por: Rudzińska, Anna, et al.
Publicado: (2023)

Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
por: Vymazal, Josef, et al.
Publicado: (2023)

Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
por: Gatson, Na Tosha N., et al.
Publicado: (2021)

The Redox Imbalance and the Reduction of Contractile Protein Content in Rat Hearts Administered with L-Thyroxine and Doxorubicin
por: Korga, Agnieszka, et al.
Publicado: (2012)

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide
por: Robins, H. Ian, et al.
Publicado: (2018)

Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
por: Palmer, Joshua D., et al.
Publicado: (2021)

Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis
por: Du, Xue, et al.
Publicado: (2022)

Challenges for computational intelligence
por: Duch, Wlodzislaw, et al.
Publicado: (2007)

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
por: Lacouture, Mario E., et al.
Publicado: (2020)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2021)

Characteristics of Fluorescent Intraoperative Dyes Helpful in Gross Total Resection of High-Grade Gliomas—A Systematic Review
por: Mazurek, Marek, et al.
Publicado: (2020)

Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy
por: Li, Taoran, et al.
Publicado: (2018)

Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
por: Miller, Ryan, et al.
Publicado: (2022)

Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity
por: Shi, Ping, et al.
Publicado: (2022)

Severe Hyponatremia in a 6-month-old Infant
por: Mańdziuk, Joanna, et al.
Publicado: (2019)

SARS-CoV-2 Cluster in Nursery, Poland
por: Okarska-Napierała, Magdalena, et al.
Publicado: (2021)

Tris (2,3-Dibromopropyl) Isocyanurate (TDBP-TAZTO or TBC) Shows Different Toxicity Depending on the Degree of Differentiation of the Human Neuroblastoma (SH-SY5Y) Cell Line
por: Szychowski, Konrad A., et al.
Publicado: (2021)

Case Report of Complete Radiological Response of a Thalamic Glioblastoma After Treatment With Proton Therapy Followed by Temozolomide and Tumor-Treating Fields
por: Stein, Marco, et al.
Publicado: (2020)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

Tirapazamine-Doxorubicin Interaction Referring to Heart Oxidative Stress and Ca(2+) Balance Protein Levels
por: Sliwinska, Justyna, et al.
Publicado: (2012)

Dietary Copper Deficiency Leads to Changes in Gene Expression Indicating an Increased Demand for NADH in the Prefrontal Cortex of the Rat’s Brain
por: Cendrowska-Pinkosz, Monika, et al.
Publicado: (2022)

Integration of Tumor‐Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
por: Wang, Yuefeng, et al.
Publicado: (2019)

A Nomogram Predicts Individual Prognosis in Patients With Newly Diagnosed Glioblastoma by Integrating the Extent of Resection of Non-Enhancing Tumors
por: Zhang, Zhe, et al.
Publicado: (2020)

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021)

The Value of Tumor Treating Fields in Glioblastoma
por: Zhang, Chaochao, et al.
Publicado: (2020)

Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
por: Carrieri, Francesca A., et al.
Publicado: (2020)

Recent Advances in General Game Playing
por: Świechowski, Maciej, et al.
Publicado: (2015)

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
por: Grenda, Anna, et al.
Publicado: (2021)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022)

New 1,3,4-Thiadiazole Derivatives with Anticancer Activity
por: Janowska, Sara, et al.
Publicado: (2022)

Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
Publicado: (2022)

Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma
por: Chi, Xiaohan, et al.
Publicado: (2022)

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021)

Current usage of tumor treating fields for glioblastoma
por: Lassman, Andrew B, et al.
Publicado: (2020)

Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
por: Dudka, Jaroslaw, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_esku5c0241tobgaa6hlloh0jq4